Atlas Venture - We build breakthrough biotechnology companies.

Creating and building breakthrough biotechs for over 30 years

Partnering with the world's best life science entrepreneurs

Translating groundbreaking science into life-changing medicines

Scroll to explore

With $100M, Vima pursues an oral drug for movement disorders

Servier to buy Day One Biopharma for $2.5 billion in tumor treatment push

Caldera launches with $112M, former Morphic CEO and IBD drug from China

Thirty years at the leading-edge of medical innovation and we’re just getting started.